Construct validity and minimal important diff erence of 6-minute walk distance in survivors of acute respiratory failure

Kitty S. Chan, Elizabeth R. Pfoh, Linda Denehy, Doug Elliott, Anne E. Holland, Victoriano Dinglas, Dale Needham

Research output: Contribution to journalArticle

Abstract

OBJECTIVE: Th e 6-min walk distance (6MWD), a widely used test of functional capacity, has limited evidence of construct validity among patients surviving acute respiratory failure (ARF) and ARDS. The objective of this study was to examine construct validity and responsiveness and estimate minimal important diff erence (MID) for the 6MWD in patients surviving ARF/ARDS . METHODS: For this secondary data analysis of four international studies of adult patients surviving ARF/ARDS (N 5 641), convergent and discriminant validity, known group validity, predictive validity, and responsiveness were assessed. MID was examined using anchor- and distribution-based approaches. Analyses were performed within studies and at various time points aft er hospital discharge to examine generalizability of fi ndings. RESULTS: Th e 6MWD demonstrated good convergent and discriminant validity, with moderate to strong correlations with physical health measures (| r | 5 0.36-0.76) and weaker correlations with mental health measures (| r | 5 0.03-0.45). Known-groups validity was demonstrated by diff erences in 6MWD between groups with diff ering muscle strength and pulmonary function (all P <.01). Patients reporting improved function walked farther, supporting responsiveness. 6MWD also predicted multiple outcomes, including future mortality, hospitalization, and health-related quality of life. Th e 6MWD MID, a small but consistent patient-perceivable effect, was 20 to 30 m. Findings were similar for 6MWD % predicted, with an MID of 3% to 5%. CONCLUSIONS: In patients surviving ARF/ARDS, the 6MWD is a valid and responsive measure of functional capacity. Th e MID will facilitate planning and interpretation of future group comparison studies in this population.

Original languageEnglish (US)
Pages (from-to)1316-1326
Number of pages11
JournalChest
Volume147
Issue number5
DOIs
StatePublished - May 1 2015

Fingerprint

Respiratory Insufficiency
Survivors
Muscle Strength
Mental Health
Hospitalization
Quality of Life
Lung
Mortality
Health
Population

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

Construct validity and minimal important diff erence of 6-minute walk distance in survivors of acute respiratory failure. / Chan, Kitty S.; Pfoh, Elizabeth R.; Denehy, Linda; Elliott, Doug; Holland, Anne E.; Dinglas, Victoriano; Needham, Dale.

In: Chest, Vol. 147, No. 5, 01.05.2015, p. 1316-1326.

Research output: Contribution to journalArticle

Chan, Kitty S. ; Pfoh, Elizabeth R. ; Denehy, Linda ; Elliott, Doug ; Holland, Anne E. ; Dinglas, Victoriano ; Needham, Dale. / Construct validity and minimal important diff erence of 6-minute walk distance in survivors of acute respiratory failure. In: Chest. 2015 ; Vol. 147, No. 5. pp. 1316-1326.
@article{94c66cbe3d0c43bc8d03c692db964c5f,
title = "Construct validity and minimal important diff erence of 6-minute walk distance in survivors of acute respiratory failure",
abstract = "OBJECTIVE: Th e 6-min walk distance (6MWD), a widely used test of functional capacity, has limited evidence of construct validity among patients surviving acute respiratory failure (ARF) and ARDS. The objective of this study was to examine construct validity and responsiveness and estimate minimal important diff erence (MID) for the 6MWD in patients surviving ARF/ARDS . METHODS: For this secondary data analysis of four international studies of adult patients surviving ARF/ARDS (N 5 641), convergent and discriminant validity, known group validity, predictive validity, and responsiveness were assessed. MID was examined using anchor- and distribution-based approaches. Analyses were performed within studies and at various time points aft er hospital discharge to examine generalizability of fi ndings. RESULTS: Th e 6MWD demonstrated good convergent and discriminant validity, with moderate to strong correlations with physical health measures (| r | 5 0.36-0.76) and weaker correlations with mental health measures (| r | 5 0.03-0.45). Known-groups validity was demonstrated by diff erences in 6MWD between groups with diff ering muscle strength and pulmonary function (all P <.01). Patients reporting improved function walked farther, supporting responsiveness. 6MWD also predicted multiple outcomes, including future mortality, hospitalization, and health-related quality of life. Th e 6MWD MID, a small but consistent patient-perceivable effect, was 20 to 30 m. Findings were similar for 6MWD {\%} predicted, with an MID of 3{\%} to 5{\%}. CONCLUSIONS: In patients surviving ARF/ARDS, the 6MWD is a valid and responsive measure of functional capacity. Th e MID will facilitate planning and interpretation of future group comparison studies in this population.",
author = "Chan, {Kitty S.} and Pfoh, {Elizabeth R.} and Linda Denehy and Doug Elliott and Holland, {Anne E.} and Victoriano Dinglas and Dale Needham",
year = "2015",
month = "5",
day = "1",
doi = "10.1378/chest.14-1808",
language = "English (US)",
volume = "147",
pages = "1316--1326",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "5",

}

TY - JOUR

T1 - Construct validity and minimal important diff erence of 6-minute walk distance in survivors of acute respiratory failure

AU - Chan, Kitty S.

AU - Pfoh, Elizabeth R.

AU - Denehy, Linda

AU - Elliott, Doug

AU - Holland, Anne E.

AU - Dinglas, Victoriano

AU - Needham, Dale

PY - 2015/5/1

Y1 - 2015/5/1

N2 - OBJECTIVE: Th e 6-min walk distance (6MWD), a widely used test of functional capacity, has limited evidence of construct validity among patients surviving acute respiratory failure (ARF) and ARDS. The objective of this study was to examine construct validity and responsiveness and estimate minimal important diff erence (MID) for the 6MWD in patients surviving ARF/ARDS . METHODS: For this secondary data analysis of four international studies of adult patients surviving ARF/ARDS (N 5 641), convergent and discriminant validity, known group validity, predictive validity, and responsiveness were assessed. MID was examined using anchor- and distribution-based approaches. Analyses were performed within studies and at various time points aft er hospital discharge to examine generalizability of fi ndings. RESULTS: Th e 6MWD demonstrated good convergent and discriminant validity, with moderate to strong correlations with physical health measures (| r | 5 0.36-0.76) and weaker correlations with mental health measures (| r | 5 0.03-0.45). Known-groups validity was demonstrated by diff erences in 6MWD between groups with diff ering muscle strength and pulmonary function (all P <.01). Patients reporting improved function walked farther, supporting responsiveness. 6MWD also predicted multiple outcomes, including future mortality, hospitalization, and health-related quality of life. Th e 6MWD MID, a small but consistent patient-perceivable effect, was 20 to 30 m. Findings were similar for 6MWD % predicted, with an MID of 3% to 5%. CONCLUSIONS: In patients surviving ARF/ARDS, the 6MWD is a valid and responsive measure of functional capacity. Th e MID will facilitate planning and interpretation of future group comparison studies in this population.

AB - OBJECTIVE: Th e 6-min walk distance (6MWD), a widely used test of functional capacity, has limited evidence of construct validity among patients surviving acute respiratory failure (ARF) and ARDS. The objective of this study was to examine construct validity and responsiveness and estimate minimal important diff erence (MID) for the 6MWD in patients surviving ARF/ARDS . METHODS: For this secondary data analysis of four international studies of adult patients surviving ARF/ARDS (N 5 641), convergent and discriminant validity, known group validity, predictive validity, and responsiveness were assessed. MID was examined using anchor- and distribution-based approaches. Analyses were performed within studies and at various time points aft er hospital discharge to examine generalizability of fi ndings. RESULTS: Th e 6MWD demonstrated good convergent and discriminant validity, with moderate to strong correlations with physical health measures (| r | 5 0.36-0.76) and weaker correlations with mental health measures (| r | 5 0.03-0.45). Known-groups validity was demonstrated by diff erences in 6MWD between groups with diff ering muscle strength and pulmonary function (all P <.01). Patients reporting improved function walked farther, supporting responsiveness. 6MWD also predicted multiple outcomes, including future mortality, hospitalization, and health-related quality of life. Th e 6MWD MID, a small but consistent patient-perceivable effect, was 20 to 30 m. Findings were similar for 6MWD % predicted, with an MID of 3% to 5%. CONCLUSIONS: In patients surviving ARF/ARDS, the 6MWD is a valid and responsive measure of functional capacity. Th e MID will facilitate planning and interpretation of future group comparison studies in this population.

UR - http://www.scopus.com/inward/record.url?scp=84929484584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929484584&partnerID=8YFLogxK

U2 - 10.1378/chest.14-1808

DO - 10.1378/chest.14-1808

M3 - Article

C2 - 25742048

AN - SCOPUS:84929484584

VL - 147

SP - 1316

EP - 1326

JO - Chest

JF - Chest

SN - 0012-3692

IS - 5

ER -